President Donald Trump’s physical Dr. Sean Conley confirmed Friday that the president is taking an experimental antibody treatment to help him fight the coronavirus following his diagnosis this ...

Regeneron’s COVID-19 antibody cocktail, casirivimab and imdevimab, reduced the risk of death among hospitalized patients in a phase 3 trial, the drugmaker said June 16. The trial found that adding ...

TARRYTOWN, N.Y. - A COVID-19 antibody cocktail developed by U.S. drugmaker Regeneron offered strong protection against symptomatic infection when given to people living with someone else infected with ...

The U.S. surpassed 12 million total COVID-19 cases Nov. 21, according to data from Baltimore-based Johns Hopkins University. The nation also reported more than 198,500 new cases Nov. 20, which is a ...

Oct 30 (Reuters) - Regeneron Pharmaceuticals (REGN.O), opens new tab said on Friday it would stop enrolling patients receiving advanced COVID-19 care in a trial testing its experimental antibody ...

Nov 17 (Reuters) - Roche Holding AG (ROG.S), opens new tab has completed early tests of its ability to produce large quantities of Regeneron Pharmaceuticals Inc's (REGN.O), opens new tab COVID-19 ...